Menu Back toSession 7: Early Access Paths in Europe

Innovative Therapies in Europe

DIA-EUCOPE Workshop: 5 Years of ATMPs on the Market - Lessons Learned

Session 7: Early Access Paths in Europe

Session Chair(s)

Michela  Gabaldo, PharmD, MSc

Michela Gabaldo, PharmD, MSc

  • Head Alliance Management & Regulatory Affairs
  • Fondazione Telethon, Italy


Oswald  Bentinck

Industry Perspective: Available Early Access Schemes

Oswald Bentinck

  • Vice President - Head of Market Access EMEA
  • Novartis Gene Therapies, Switzerland

Contact us

Registration Questions?

Send Email
+41 61 225 51 51